NAROPEINE 2 mg/ml, solution for injection in an ampoule 5 ampoules of 20 ml
Active ingredients: Ropivacaine hydrochloride, (S)-N-(2,6-dimethylphenyl)-1-ethylpiperidine-2-carboxamide
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection5 ampoules of 20 mlinfiltration;péridurale;périneurale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NAROPEINE 2 mg/ml, solution injectable en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- infiltration;péridurale;périneurale
- Presentation description
- 5 ampoule(s) polypropylène de 20 ml sous barquette stérile
- Marketing authorisation holder
- ASPEN PHARMA TRADING (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Apr 2025
- Prescription and dispensing conditions
- Prescription only, hospital use
- List II: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67480631CIP75599220CIP133400955992202Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE ROPIVACAÏNE MONOHYDRATÉsolution | 2,12 mg · 1 ml | SA |
| CHLORHYDRATE DE ROPIVACAÏNE ANHYDREsolution | 2,00 mg · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.